Xcell Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Xcell Biosciences's estimated annual revenue is currently $6.2M per year.
- Xcell Biosciences's estimated revenue per employee is $155,000
Employee Data
- Xcell Biosciences has 40 Employees.
- Xcell Biosciences grew their employee count by 25% last year.
Xcell Biosciences's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO / Founder | Reveal Email/Phone |
2 | VP Engineering | Reveal Email/Phone |
3 | Head Application Development | Reveal Email/Phone |
4 | Associate Director, Product Management | Reveal Email/Phone |
5 | Director Operations | Reveal Email/Phone |
6 | Chief Technology Officer | Reveal Email/Phone |
7 | Chief Scientific Officer | Reveal Email/Phone |
8 | Director Product Engineering | Reveal Email/Phone |
9 | Office Operations Manager | Reveal Email/Phone |
10 | Mechanical Design Engineer | Reveal Email/Phone |
Xcell Biosciences Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Xcell Biosciences?
Xcell Bio is a San Francisco-based life science company dedicated to bringing an innovative primary cell control solution to the immunotherapy market to support research, drug discovery, and cell manufacturing. Xcell's mission is to democratize maintenance, expansion and control of any primary cell type through its bench-top primary cell control systems, reagent kits, software, and standardized protocols. The technology delivers simple control of primary cell types from blood or solid tissue, including a range of immune cells, stem cells, and tumor cells. This patient-centric technology offers a unique and proprietary capability to improve immunotherapy efficacy, safety, and persistence through more predictive and iterative therapy development and rapid, highly-controlled clinical cell manufacturing. For more information, please visit http://www.xcellbio.com/.
keywords:N/AN/A
Total Funding
40
Number of Employees
$6.2M
Revenue (est)
25%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Xcell Biosciences News
The diagnostics and drug development company, Labcorp, is partnering with San Francisco based, Xcell Biosciences, to advance efforts to help...
... is collaborating with Xcell Biosciences, Inc. (Xcellbio), a leading developer of cell and gene therapy technologies, to advance critical...
Credit: Laboratory Corporation of America Holdings. Labcorp has announced collaboration with Xcell Biosciences to progress activities that would...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $8.2M | 40 | 90% | $14.5M |
#2 | $4.4M | 40 | -5% | $60M |
#3 | $7.5M | 40 | 5% | N/A |
#4 | $4.5M | 40 | -76% | N/A |
#5 | $8.1M | 40 | N/A | N/A |